FDA Inspection 1071326 — Covis Pharma GmBH
The FDA completed an inspection of Covis Pharma GmBH on October 22, 2018 in Waltham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 22, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Waltham, MA (United States)
Additional Details
Sponsor, Contract Research Organization